APO Research
Talk to an analyst

APO RESEARCH · REPORT

Talazoparib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Talazoparib Market Analysis and Forecast 2026-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchTalazoparib Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Talazoparib Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Talazoparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Talazoparib Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Talazoparib Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Talazoparib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Talazoparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Talazoparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Talazoparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Talazoparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Talazoparib include Pfizer. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Talazoparib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Talazoparib, also provides the sales of main regions and countries. Of the upcoming market potential for Talazoparib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Talazoparib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Talazoparib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Talazoparib sales, projected growth trends, production technology, application and end-user industry.

Talazoparib Segment by Company

Pfizer

Talazoparib Segment by Type

0.25mg Capsules

1mg Capsules

Talazoparib Segment by Application

Clinic

Hospital

Drug Center

Others

Talazoparib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Talazoparib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Talazoparib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Talazoparib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Talazoparib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Talazoparib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Talazoparib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Talazoparib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.25mg Capsules Major Manufacturers Table 3. 1mg Capsules Major Manufacturers Table 4. Global Talazoparib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Drug Center Major Manufacturers Table 8. Others Major Manufacturers Table 9. Talazoparib Industry Trends Table 10. Talazoparib Industry Drivers Table 11. Talazoparib Industry Opportunities and Challenges Table 12. Talazoparib Industry Restraints Table 13. Global Talazoparib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Talazoparib Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Talazoparib Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Talazoparib Revenue Market Share by Region (2021-2026) Table 17. Global Talazoparib Revenue Market Share by Region (2027-2032) Table 18. Global Talazoparib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Talazoparib Sales by Region (2021-2026) & (k units) Table 20. Global Talazoparib Sales by Region (2027-2032) & (k units) Table 21. Global Talazoparib Sales Market Share by Region (2021-2026) Table 22. Global Talazoparib Sales Market Share by Region (2027-2032) Table 23. Global Talazoparib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Talazoparib Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Talazoparib Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Talazoparib Sales Market Share by Manufacturers (2021-2026) Table 27. Global Talazoparib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Talazoparib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Talazoparib Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Talazoparib Manufacturers, Product Type & Application Table 31. Global Talazoparib Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Talazoparib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Talazoparib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Talazoparib Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Talazoparib Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Talazoparib Revenue Market Share by Type (2021-2026) Table 38. Global Talazoparib Revenue Market Share by Type (2027-2032) Table 39. Global Talazoparib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Talazoparib Sales by Type (2021-2026) & (k units) Table 41. Global Talazoparib Sales by Type (2027-2032) & (k units) Table 42. Global Talazoparib Sales Market Share by Type (2021-2026) Table 43. Global Talazoparib Sales Market Share by Type (2027-2032) Table 44. Global Talazoparib Price by Type (2021-2026) & (US$/unit) Table 45. Global Talazoparib Price by Type (2027-2032) & (US$/unit) Table 46. Global Talazoparib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Talazoparib Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Talazoparib Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Talazoparib Revenue Market Share by Application (2021-2026) Table 50. Global Talazoparib Revenue Market Share by Application (2027-2032) Table 51. Global Talazoparib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Talazoparib Sales by Application (2021-2026) & (k units) Table 53. Global Talazoparib Sales by Application (2027-2032) & (k units) Table 54. Global Talazoparib Sales Market Share by Application (2021-2026) Table 55. Global Talazoparib Sales Market Share by Application (2027-2032) Table 56. Global Talazoparib Price by Application (2021-2026) & (US$/unit) Table 57. Global Talazoparib Price by Application (2027-2032) & (US$/unit) Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Talazoparib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Pfizer Talazoparib Product Portfolio Table 62. Pfizer Recent Development Table 63. North America Talazoparib Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Talazoparib Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Talazoparib Sales by Type (2021-2026) & (k units) Table 66. North America Talazoparib Sales by Type (2027-2032) & (k units) Table 67. North America Talazoparib Sales Price by Type (2021-2026) & (US$/unit) Table 68. North America Talazoparib Sales Price by Type (2027-2032) & (US$/unit) Table 69. North America Talazoparib Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Talazoparib Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Talazoparib Sales by Application (2021-2026) & (k units) Table 72. North America Talazoparib Sales by Application (2027-2032) & (k units) Table 73. North America Talazoparib Sales Price by Application (2021-2026) & (US$/unit) Table 74. North America Talazoparib Sales Price by Application (2027-2032) & (US$/unit) Table 75. North America Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Talazoparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 77. North America Talazoparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 78. North America Talazoparib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 79. North America Talazoparib Sales by Country (2021-2026) & (k units) Table 80. North America Talazoparib Sales by Country (2027-2032) & (k units) Table 81. North America Talazoparib Sales Price by Country (2021-2026) & (US$/unit) Table 82. North America Talazoparib Sales Price by Country (2027-2032) & (US$/unit) Table 83. United States Talazoparib Revenue (2021-2032) & (US$ Million) Table 84. Canada Talazoparib Revenue (2021-2032) & (US$ Million) Table 85. Mexico Talazoparib Revenue (2021-2032) & (US$ Million) Table 86. Europe Talazoparib Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Talazoparib Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Talazoparib Sales by Type (2021-2026) & (k units) Table 89. Europe Talazoparib Sales by Type (2027-2032) & (k units) Table 90. Europe Talazoparib Sales Price by Type (2021-2026) & (US$/unit) Table 91. Europe Talazoparib Sales Price by Type (2027-2032) & (US$/unit) Table 92. Europe Talazoparib Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Talazoparib Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Talazoparib Sales by Application (2021-2026) & (k units) Table 95. Europe Talazoparib Sales by Application (2027-2032) & (k units) Table 96. Europe Talazoparib Sales Price by Application (2021-2026) & (US$/unit) Table 97. Europe Talazoparib Sales Price by Application (2027-2032) & (US$/unit) Table 98. Europe Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Talazoparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. Europe Talazoparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. Europe Talazoparib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 102. Europe Talazoparib Sales by Country (2021-2026) & (k units) Table 103. Europe Talazoparib Sales by Country (2027-2032) & (k units) Table 104. Europe Talazoparib Sales Price by Country (2021-2026) & (US$/unit) Table 105. Europe Talazoparib Sales Price by Country (2027-2032) & (US$/unit) Table 106. Germany Talazoparib Revenue (2021-2032) & (US$ Million) Table 107. France Talazoparib Revenue (2021-2032) & (US$ Million) Table 108. U.K. Talazoparib Revenue (2021-2032) & (US$ Million) Table 109. Italy Talazoparib Revenue (2021-2032) & (US$ Million) Table 110. Russia Talazoparib Revenue (2021-2032) & (US$ Million) Table 111. Spain Talazoparib Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Talazoparib Revenue (2021-2032) & (US$ Million) Table 113. Switzerland Talazoparib Revenue (2021-2032) & (US$ Million) Table 114. Sweden Talazoparib Revenue (2021-2032) & (US$ Million) Table 115. Poland Talazoparib Revenue (2021-2032) & (US$ Million) Table 116. China Talazoparib Revenue by Type (2021-2026) & (US$ Million) Table 117. China Talazoparib Revenue by Type (2027-2032) & (US$ Million) Table 118. China Talazoparib Sales by Type (2021-2026) & (k units) Table 119. China Talazoparib Sales by Type (2027-2032) & (k units) Table 120. China Talazoparib Sales Price by Type (2021-2026) & (US$/unit) Table 121. China Talazoparib Sales Price by Type (2027-2032) & (US$/unit) Table 122. China Talazoparib Revenue by Application (2021-2026) & (US$ Million) Table 123. China Talazoparib Revenue by Application (2027-2032) & (US$ Million) Table 124. China Talazoparib Sales by Application (2021-2026) & (k units) Table 125. China Talazoparib Sales by Application (2027-2032) & (k units) Table 126. China Talazoparib Sales Price by Application (2021-2026) & (US$/unit) Table 127. China Talazoparib Sales Price by Application (2027-2032) & (US$/unit) Table 128. Asia Talazoparib Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Talazoparib Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Talazoparib Sales by Type (2021-2026) & (k units) Table 131. Asia Talazoparib Sales by Type (2027-2032) & (k units) Table 132. Asia Talazoparib Sales Price by Type (2021-2026) & (US$/unit) Table 133. Asia Talazoparib Sales Price by Type (2027-2032) & (US$/unit) Table 134. Asia Talazoparib Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Talazoparib Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Talazoparib Sales by Application (2021-2026) & (k units) Table 137. Asia Talazoparib Sales by Application (2027-2032) & (k units) Table 138. Asia Talazoparib Sales Price by Application (2021-2026) & (US$/unit) Table 139. Asia Talazoparib Sales Price by Application (2027-2032) & (US$/unit) Table 140. Asia Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Talazoparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Asia Talazoparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Asia Talazoparib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. Asia Talazoparib Sales by Country (2021-2026) & (k units) Table 145. Asia Talazoparib Sales by Country (2027-2032) & (k units) Table 146. Asia Talazoparib Sales Price by Country (2021-2026) & (US$/unit) Table 147. Asia Talazoparib Sales Price by Country (2027-2032) & (US$/unit) Table 148. Japan Talazoparib Revenue (2021-2032) & (US$ Million) Table 149. South Korea Talazoparib Revenue (2021-2032) & (US$ Million) Table 150. India Talazoparib Revenue (2021-2032) & (US$ Million) Table 151. Australia Talazoparib Revenue (2021-2032) & (US$ Million) Table 152. Taiwan Talazoparib Revenue (2021-2032) & (US$ Million) Table 153. Southeast Asia Talazoparib Revenue (2021-2032) & (US$ Million) Table 154. SAMEA Talazoparib Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Talazoparib Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Talazoparib Sales by Type (2021-2026) & (k units) Table 157. SAMEA Talazoparib Sales by Type (2027-2032) & (k units) Table 158. SAMEA Talazoparib Sales Price by Type (2021-2026) & (US$/unit) Table 159. SAMEA Talazoparib Sales Price by Type (2027-2032) & (US$/unit) Table 160. SAMEA Talazoparib Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Talazoparib Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Talazoparib Sales by Application (2021-2026) & (k units) Table 163. SAMEA Talazoparib Sales by Application (2027-2032) & (k units) Table 164. SAMEA Talazoparib Sales Price by Application (2021-2026) & (US$/unit) Table 165. SAMEA Talazoparib Sales Price by Application (2027-2032) & (US$/unit) Table 166. SAMEA Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Talazoparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. SAMEA Talazoparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. SAMEA Talazoparib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 170. SAMEA Talazoparib Sales by Country (2021-2026) & (k units) Table 171. SAMEA Talazoparib Sales by Country (2027-2032) & (k units) Table 172. SAMEA Talazoparib Sales Price by Country (2021-2026) & (US$/unit) Table 173. SAMEA Talazoparib Sales Price by Country (2027-2032) & (US$/unit) Table 174. Brazil Talazoparib Revenue (2021-2032) & (US$ Million) Table 175. Argentina Talazoparib Revenue (2021-2032) & (US$ Million) Table 176. Chile Talazoparib Revenue (2021-2032) & (US$ Million) Table 177. Colombia Talazoparib Revenue (2021-2032) & (US$ Million) Table 178. Peru Talazoparib Revenue (2021-2032) & (US$ Million) Table 179. Saudi Arabia Talazoparib Revenue (2021-2032) & (US$ Million) Table 180. Israel Talazoparib Revenue (2021-2032) & (US$ Million) Table 181. UAE Talazoparib Revenue (2021-2032) & (US$ Million) Table 182. Turkey Talazoparib Revenue (2021-2032) & (US$ Million) Table 183. Iran Talazoparib Revenue (2021-2032) & (US$ Million) Table 184. Egypt Talazoparib Revenue (2021-2032) & (US$ Million) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Talazoparib Distributors List Table 188. Talazoparib Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Talazoparib Image Figure 2. Global Talazoparib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Talazoparib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.25mg Capsules Image Figure 5. 1mg Capsules Image Figure 6. Global Talazoparib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Talazoparib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Drug Center Image Figure 11. Others Image Figure 12. Global Talazoparib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Talazoparib Revenue (2021-2032) & (US$ Million) Figure 14. Global Talazoparib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Talazoparib Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Talazoparib Revenue Market Share by Region (2021-2032) Figure 17. Global Talazoparib Sales (2021-2032) & (k units) Figure 18. Global Talazoparib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Talazoparib Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Talazoparib Sales YoY (2021-2032) & (k units) Figure 21. Europe Talazoparib Sales YoY (2021-2032) & (k units) Figure 22. China Talazoparib Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Talazoparib Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Talazoparib Sales YoY (2021-2032) & (k units) Figure 25. Global Talazoparib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Talazoparib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Talazoparib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Talazoparib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Talazoparib Revenue Market Share by Type (2021-2032) Figure 31. Global Talazoparib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Talazoparib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Talazoparib Sales Market Share by Type (2021-2032) Figure 34. Global Talazoparib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Talazoparib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Talazoparib Revenue Market Share by Application (2021-2032) Figure 37. Global Talazoparib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Talazoparib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Talazoparib Sales Market Share by Application (2021-2032) Figure 40. North America Talazoparib Revenue Share by Type (2021-2032) Figure 41. North America Talazoparib Sales Share by Type (2021-2032) Figure 42. North America Talazoparib Revenue Share by Application (2021-2032) Figure 43. North America Talazoparib Sales Share by Application (2021-2032) Figure 44. North America Talazoparib Revenue Share by Country (2021-2032) Figure 45. North America Talazoparib Sales Share by Country (2021-2032) Figure 46. Europe Talazoparib Revenue Share by Type (2021-2032) Figure 47. Europe Talazoparib Sales Share by Type (2021-2032) Figure 48. Europe Talazoparib Revenue Share by Application (2021-2032) Figure 49. Europe Talazoparib Sales Share by Application (2021-2032) Figure 50. Europe Talazoparib Revenue Share by Country (2021-2032) Figure 51. Europe Talazoparib Sales Share by Country (2021-2032) Figure 52. China Talazoparib Revenue Share by Type (2021-2032) Figure 53. China Talazoparib Sales Share by Type (2021-2032) Figure 54. China Talazoparib Revenue Share by Application (2021-2032) Figure 55. China Talazoparib Sales Share by Application (2021-2032) Figure 56. Asia Talazoparib Revenue Share by Type (2021-2032) Figure 57. Asia Talazoparib Sales Share by Type (2021-2032) Figure 58. Asia Talazoparib Revenue Share by Application (2021-2032) Figure 59. Asia Talazoparib Sales Share by Application (2021-2032) Figure 60. Asia Talazoparib Revenue Share by Country (2021-2032) Figure 61. Asia Talazoparib Sales Share by Country (2021-2032) Figure 62. SAMEA Talazoparib Revenue Share by Type (2021-2032) Figure 63. SAMEA Talazoparib Sales Share by Type (2021-2032) Figure 64. SAMEA Talazoparib Revenue Share by Application (2021-2032) Figure 65. SAMEA Talazoparib Sales Share by Application (2021-2032) Figure 66. SAMEA Talazoparib Revenue Share by Country (2021-2032) Figure 67. SAMEA Talazoparib Sales Share by Country (2021-2032) Figure 68. Talazoparib Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Talazoparib Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25mg Capsules
  • 1mg Capsules
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Talazoparib Market by Type
  3. 1.2.1 Global Talazoparib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.25mg Capsules
  5. 1.2.3 1mg Capsules
  6. 1.3 Talazoparib Market by Application
  7. 1.3.1 Global Talazoparib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Drug Center
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Talazoparib Market Dynamics
  1. 2.1 Talazoparib Industry Trends
  2. 2.2 Talazoparib Industry Drivers
  3. 2.3 Talazoparib Industry Opportunities and Challenges
  4. 2.4 Talazoparib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Talazoparib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Talazoparib Revenue by Region
  3. 3.2.1 Global Talazoparib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Talazoparib Revenue by Region (2021-2026)
  5. 3.2.3 Global Talazoparib Revenue by Region (2027-2032)
  6. 3.2.4 Global Talazoparib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Talazoparib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Talazoparib Sales by Region
  9. 3.4.1 Global Talazoparib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Talazoparib Sales by Region (2021-2026)
  11. 3.4.3 Global Talazoparib Sales by Region (2027-2032)
  12. 3.4.4 Global Talazoparib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Talazoparib Revenue by Manufacturers
  2. 4.1.1 Global Talazoparib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Talazoparib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Talazoparib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Talazoparib Sales by Manufacturers
  6. 4.2.1 Global Talazoparib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Talazoparib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Talazoparib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Talazoparib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Talazoparib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Talazoparib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Talazoparib Manufacturers, Product Type & Application
  13. 4.7 Global Talazoparib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Talazoparib Market CR5 and HHI
  16. 4.8.2 2025 Talazoparib Tier 1, Tier 2, and Tier 3
5 Talazoparib Market by Type
  1. 5.1 Global Talazoparib Revenue by Type
  2. 5.1.1 Global Talazoparib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Talazoparib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Talazoparib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Talazoparib Sales by Type
  6. 5.2.1 Global Talazoparib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Talazoparib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Talazoparib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Talazoparib Price by Type
6 Talazoparib Market by Application
  1. 6.1 Global Talazoparib Revenue by Application
  2. 6.1.1 Global Talazoparib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Talazoparib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Talazoparib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Talazoparib Sales by Application
  6. 6.2.1 Global Talazoparib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Talazoparib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Talazoparib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Talazoparib Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Talazoparib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Talazoparib Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Talazoparib Market Size by Type
  2. 8.1.1 North America Talazoparib Revenue by Type (2021-2032)
  3. 8.1.2 North America Talazoparib Sales by Type (2021-2032)
  4. 8.1.3 North America Talazoparib Price by Type (2021-2032)
  5. 8.2 North America Talazoparib Market Size by Application
  6. 8.2.1 North America Talazoparib Revenue by Application (2021-2032)
  7. 8.2.2 North America Talazoparib Sales by Application (2021-2032)
  8. 8.2.3 North America Talazoparib Price by Application (2021-2032)
  9. 8.3 North America Talazoparib Market Size by Country
  10. 8.3.1 North America Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Talazoparib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Talazoparib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Talazoparib Market Size by Type
  2. 9.1.1 Europe Talazoparib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Talazoparib Sales by Type (2021-2032)
  4. 9.1.3 Europe Talazoparib Price by Type (2021-2032)
  5. 9.2 Europe Talazoparib Market Size by Application
  6. 9.2.1 Europe Talazoparib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Talazoparib Sales by Application (2021-2032)
  8. 9.2.3 Europe Talazoparib Price by Application (2021-2032)
  9. 9.3 Europe Talazoparib Market Size by Country
  10. 9.3.1 Europe Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Talazoparib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Talazoparib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Talazoparib Market Size by Type
  2. 10.1.1 China Talazoparib Revenue by Type (2021-2032)
  3. 10.1.2 China Talazoparib Sales by Type (2021-2032)
  4. 10.1.3 China Talazoparib Price by Type (2021-2032)
  5. 10.2 China Talazoparib Market Size by Application
  6. 10.2.1 China Talazoparib Revenue by Application (2021-2032)
  7. 10.2.2 China Talazoparib Sales by Application (2021-2032)
  8. 10.2.3 China Talazoparib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Talazoparib Market Size by Type
  2. 11.1.1 Asia Talazoparib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Talazoparib Sales by Type (2021-2032)
  4. 11.1.3 Asia Talazoparib Price by Type (2021-2032)
  5. 11.2 Asia Talazoparib Market Size by Application
  6. 11.2.1 Asia Talazoparib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Talazoparib Sales by Application (2021-2032)
  8. 11.2.3 Asia Talazoparib Price by Application (2021-2032)
  9. 11.3 Asia Talazoparib Market Size by Country
  10. 11.3.1 Asia Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Talazoparib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Talazoparib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Talazoparib Market Size by Type
  2. 12.1.1 SAMEA Talazoparib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Talazoparib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Talazoparib Price by Type (2021-2032)
  5. 12.2 SAMEA Talazoparib Market Size by Application
  6. 12.2.1 SAMEA Talazoparib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Talazoparib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Talazoparib Price by Application (2021-2032)
  9. 12.3 SAMEA Talazoparib Market Size by Country
  10. 12.3.1 SAMEA Talazoparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Talazoparib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Talazoparib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Talazoparib Value Chain Analysis
  2. 13.1.1 Talazoparib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Talazoparib Production Mode & Process
  6. 13.2 Talazoparib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Talazoparib Distributors
  9. 13.2.3 Talazoparib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst